Medican Enterprises, Inc.

MDCN

US58464T2024

Pharmaceuticals

Delayed OTC Markets Other stock markets 09:59:07 09/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2021	Medican Enterprises, Inc. acquired an unknown stake in Equity Apple, Inc.	CI
2021	Medican Enterprises, Inc. acquired 49% stake in R & B Property Development LLC.	CI

Medican Enterprises, Inc. to Remove Ken Williams as Secretary and Director

October 07, 2015 at 09:11 pm IST

Medican Enterprises, Inc. announced that, on September 23, 2015 with a special meeting of the Board of Directors it was resolved to remove Ken Williams as Secretary and Director.

Latest news about Medican Enterprises, Inc.

Medican Enterprises, Inc. acquired an unknown stake in Equity Apple, Inc.	24/21/24	CI
Medican Enterprises, Inc. acquired 49% stake in R & B Property Development LLC.	28/21/28	CI
Medican Enterprises, Inc. cancelled the acquisition of Chuck's Vintage Inc.	21/19/21	CI
Medican Enterprises, Inc. Announces Executive Change	04/19/04	CI
Medican Enterprises, Inc. acquired Chuck's Vintage Inc.	04/19/04	CI
The Now Corporation acquired majority assets of Medican Enterprises, Inc..	08/19/08	CI
Medican Enterprises, Inc. to Remove Ken Williams as Secretary and Director	07/15/07	CI
Medican Enterprises Enters into an Agreement with Music Quest Entertainment Studio	04/15/04	CI
Medican Enterprises, Inc. Signs Joint Venture with El Encanto Vineyards in Creating Newly Branded Moscato Wine	11/15/11	CI
Medican Enterprises, Inc. Accepts Resignation of Gary Johnson as Member of the Board of Directors	18/15/18	CI
Medican Enterprises, Inc. will Change its Ticker to MDCN from MDCND	15/15/15	CI
Medican Enterprises, Inc. (OTCPK:MDCN.D) completed the acquisition of TWYNS.	06/15/06	CI
Medican Enterprises, Inc. (OTCPK:MDCN.D) signed a definitive agreement to acquire TWYNS for $0.6 million.	28/15/28	CI
Medican Enterprises, Inc. will Change its Ticker to MDCND from MDCN	20/15/20	CI
Medican Enterprises Extends Closing On Two Phoenix Area Properties	18/15/18	CI
Medican Enterprises, Inc. Auditor Raises 'Going Concern' Doubt	15/15/15	CI
Medican Enterprises Inc. Receives Zoning Approval for Marijuana Business Operations	25/15/25	CI
Medican Enterprises Buys 7,200 Sq. Ft. Retail and Commercial Property in Phoenix	23/15/23	CI
Medican Enterprises, Inc. announced that it has received $0.05 million in funding from RDW Capital, LLC.	16/15/16	CI
Medican Enterprises, Inc. announced that it has received $0.05 million in funding from KBM Worldwide, Inc.	16/15/16	CI
Medican Enterprises, Inc. announced that it expects to receive $0.05 million in funding from KBM Worldwide, Inc.	14/15/14	CI
Medican Enterprises, Inc. announced that it has received $0.0825 million in funding from Tangiers Investment Group LLC	09/14/09	CI
Medican to Launch Real Estate Leasing and Marijuana Services Business	02/14/02	CI
Medican Enterprises, Inc. Appoints Gary Johnson to its Board of Directors, Effective January 23, 2014	01/14/01	CI
Medican Enterprises, Inc. announced that it has received $0.04 million in funding from KBM Worldwide, Inc.	26/14/26	CI

Chart Medican Enterprises, Inc.

Duration

Period

More charts

Medican Enterprises, Inc. is engaged in residential and commercial real estate investment and development. The Company has relationships with equity suppliers, such as individual, commercial and institutional sources. The Company is specialized in value-added investment and development in A location in urban infill areas. The Companyâs subsidiary, Immediate Properties LLC, is a real estate company. Immediate Properties LLC is engaged in multifamily, retail, office, mixed-use, adaptive re-use of industrial buildings and historic renovations. Its investment portfolio includes properties across Northern and Southern California, Atlanta, and Nevada. The Company invests in California and other select metro areas.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MEDICAN ENTERPRISES, INC.	0.00%	38.94K
ELI LILLY AND COMPANY	+29.21%	684B
NOVO NORDISK A/S	+30.34%	568B
JOHNSON & JOHNSON	-3.85%	361B
MERCK & CO., INC.	+17.64%	329B
ABBVIE INC.	+4.29%	284B
ASTRAZENECA PLC	+16.21%	240B
NOVARTIS AG	+9.66%	208B
ROCHE HOLDING AG	-6.83%	200B
AMGEN INC.	+7.26%	166B

Other Pharmaceuticals